Succinic Acid

Succinic Acid

SCHEMBL3168781

CN1CCN(Cc2ccc(C(=O)NN(c3nc(C#N)ncc3Br)C3CCCC3)cc2)CC1.O=C(O)CCC(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 5/20 0.67
CTSK P43235 5/20 0.67
CTSL P07711 4/20 0.67
CTSB P07858 1/20 0.67
HDAC6 Q9UBN7 2/20 0.43
TBK1 Q9UHD2 3/20 0.40
IKBKE Q14164 2/20 0.38
ABL1 P00519 4/20 0.37
HDAC1 Q13547 2/20 0.37
PRKAA2 P54646 2/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
F10 P00742 1/20 0.36
BTK Q06187 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3168779 0.96 CTSS (0.71) CTSSCTSKCTSLCTSBHDAC6
SCHEMBL3168821 0.95 CTSS (0.70) CTSSCTSKCTSLCTSBHDAC6
Hydrochloric Acid SCHEMBL3169383 0.95 CTSS (0.70) CTSSCTSKCTSLCTSBHDAC6
Fumaric Acid SCHEMBL3166690 0.93 CTSS (0.66) CTSSCTSKCTSLCTSBHDAC6
Fumaric Acid SCHEMBL3166701 0.93 CTSS (0.66) CTSSCTSKCTSLCTSBHDAC6
Trifluoroacetic Acid SCHEMBL3174605 0.92 CTSS (0.65) CTSSCTSKCTSLCTSBHDAC6
Trifluoroacetic Acid SCHEMBL3180549 0.92 CTSS (0.64) CTSSCTSKCTSLCTSBHDAC6
SCHEMBL3174455 0.90 CTSS (0.64) CTSSCTSKCTSLCTSBHDAC6
SCHEMBL3165989 0.90 CTSS (0.66) CTSSCTSKCTSLCTSBHDAC6
SCHEMBL3176619 0.90 CTSS (0.68) CTSSCTSKCTSLCTSBHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009956-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS Glaxo Group Limited , a corporation 2010-01-14 US claimed
US-20100009956-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS Glaxo Group Limited , a corporation 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009956-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS SERPINB1, CTRL, PRSS1 CTSS 15/4885CTSK 65/4885CTSL 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.